Document is current
Any future updates will be listed below
-
Authors
Cao, Xiaolong https://orcid.org/0000-0001-8124-7491
Zhang, Yeting
Abdulkadir, Mohamed
Deng, Li
Fernandez, Thomas V. https://orcid.org/0000-0003-0830-022X
Garcia-Delgar, Blanca
Hagstrøm, Julie https://orcid.org/0000-0003-4337-307X
Hoekstra, Pieter J.
King, Robert A.
Koesterich, Justin https://orcid.org/0000-0001-8195-5666
Kuperman, Samuel
Morer, Astrid
Nasello, Cara
Plessen, Kerstin J.
Thackray, Joshua K. https://orcid.org/0000-0003-2828-452X
Zhou, Lisheng
,
Brown, Lawrence W.
Cao, Xiaolong
Coffey, Barbara J.
Gilbert, Donald L.
Hedderly, Tammy
Heyman, Isobel
Huyser, Chaim
Kim, Eunjoo
Kim, Young-Shin
Koh, Yun-Joo
Leventhal, Bennett L.
Madruga-Garrido, Marcos
Maras, Athanasios
Mir, Pablo
Münchau, Alexander
Roessner, Veit
Song, Dong-Ho
State, Matthew W.
Willsey, A. Jeremy
Zinner, Samuel H.
Dietrich, Andrea
Tischfield, Jay A.
Heiman, Gary A. https://orcid.org/0000-0001-5859-0259
Xing, Jinchuan https://orcid.org/0000-0001-6469-8733
- License Information
-
More Information
Article History
Received: 26 November 2020
Revised: 17 March 2021
Accepted: 30 March 2021
First Online: 9 April 2021
Compliance with ethical standards
:
: BJC received research support from NIMH, Emalex, and Teva/Nuvelution; honoraria from American Academy of Child and Adolescent Psychiatry, Harvard Medical School/Psychiatry Academy, and Partners Healthcare. BJC served on the advisory board of Skyland Trail and Teva/Nuvelution, and the following roles at the Tourette Association of America: Co-Chair, Medical Advisory Board; TAA-CDC Partnership. VR has served as advisor or consultancy role for Lilly, Novartis, and Shire, and received conference attendance support or was paid for public speaking by Actelion, Lilly, Medice, Novartis and Shire.
